Latest News and Press Releases
Want to stay updated on the latest news?
-
Visiongain has published a new report entitled Cancer Immunotherapy Market Report 2024-2034: Cancer Immunotherapy Market Report 2024-2034: Forecasts by Technology (Monoclonal Antibodies,...
-
Visiongain has published a new report entitled Biological Safety Testing Market Report 2024-2034: Forecasts by Products (Consumables, Instruments, Services & Others), by Application (Cellular...
-
Visiongain has published a new report entitled Synthetic Immunology Market Report 2024-2034: Forecasts by Type (Synthetic Antibodies, Synthetic Vaccines, Synthetic Adjuvants, Synthetic...
-
Visiongain has published a new report entitled Rare Diseases Market Report 2024-2034: Forecasts by Diseases (Cancer, Metabolic Diseases, Neurological Conditions, Hematologic Disorders, Infectious...
-
Visiongain has published a new report entitled Decentralised Clinical Trials Market Report 2024-2034: Forecasts by Study Design (Interventional, Observational, Expanded Access), by Indication...
-
Visiongain has published a new report entitled Fill-Finish Manufacturing Market Report 2024-2034: Forecasts by Product (Instruments, Consumables), by Instrument (System Type (Integrated System,...
-
Visiongain has published a new report entitled Gene Therapy R&D Market Report 2024-2034: Forecasts by Disease (Cancer, Rare Diseases (Oncologic, Non-oncologic), Cardiovascular Diseases, Ophthalmic...
-
Visiongain has published a new report: Genome Editing Technologies Market Report 2024-2034: Forecasts by Technology (CRISPR, TALEN, ZFN, Meganucleases, Others), by Application (Genetic Engineering...
-
Visiongain has published a new report entitled Mobile and Digital Health Technologies Market Report 2024-2034: Forecasts by Technology (Tele-healthcare (Telecare (Activity Monitoring, Remote...
-
Visiongain has published a new report entitled Clinical Trial Supply and Logistics Market for Pharma 2024-2034: Forecasts by Type (CTS Manufacturing, CTS Logistics & Distribution, CT Supply Chain,...